Australia's most trusted
source of pharma news
Saturday, 12 July 2025
Posted 10 July 2025 AM
Big changes are coming to CSL's R&D operations, including a reduction in global headcount as the ASX giant consolidates its efforts in six sites, including Melbourne.
The plan comes after a strategic review into its R&D operations, with the aim of better positioning CSL for long-term success in a rapidly evolving global pharmaceutical industry.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.